However, MK-2206 disrupts the interaction, rendering the cells sensitive to the treatment, indicating that the sensitivity of NSCLC cells relies on disrupting the pAKT(Ser473)–EGFR complex. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.